Is Ecolab Stock Underperforming the Nasdaq?

Is Ecolab Stock Underperforming the Nasdaq?

Fri, September 4, 2026 at 3:53 PM GMT+3 3 min read

• ECL +0.11%
• ^IXIC -0.29%

Saint Paul, Minnesota-based Ecolab Inc. (ECL) is a global provider of water, hygiene, and infection-prevention solutions. Its business combines specialty chemicals, equipment, digital technologies, and on-site services to help customers improve food safety, maintain clean environments, and use water and energy more efficiently. The company has a market cap of $78.5 billion and operates through four segments: Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences.

Companies with a market cap between $10 billion and $200 billion are typically referred to as "large-cap stocks." ECL fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the specialty chemicals industry. It is a global leader in helping businesses run cleaner, safer, and more efficiently while managing critical resources such as water and energy.

More News from Barchart

Despite its strength, ECL stock slipped 9.8% from its 52-week high of $309.27, reached on Feb. 24. The stock is up 9.1% over the past three months, compared to the Nasdaq Composite's ($NASX) 1% fall during the same time frame.

However, ECL has lagged behind the broader market over the longer term. The stock has increased 2.1% over the past 52 weeks, while NASX delivered 23.7% returns over the same time frame. In 2026, ECL is up 6.3%, trailing the index's 14.4% rise.

Still, the stock's recent technical picture offers a more encouraging signal. Since the end of June, ECL has mostly traded above both its 50-day and 200-day moving averages, suggesting that the shares have been building an uptrend.

Ecolab has underperformed the broader market over the past year as uneven industrial demand, cost pressures, and investor caution around growth and valuation have weighed on its shares. The company's $4.75 billion acquisition of CoolIT Systems has also added execution and capital-allocation considerations, with its expected earnings contribution back-loaded to 2028.

However, that caution has not stopped Ecolab from delivering. On July 28, the company reported Q2 FY2026 sales growth of 9.7% to $4.42 billion and non-GAAP EPS growth of 10.6% to $2.09, topping estimates and sending shares up about 4.2%. Improved pricing and volume growth helped drive the results, while management raised its full-year adjusted diluted EPS guidance to $8.05–$8.25, representing 7%–10% growth.

Its peer, The Sherwin-Williams Company (SHW), has declined 8.5% over the past year and has gained 2.5% in 2026 trailing ECL.

Wall Street is taking a moderately optimistic stance on ECL. Among the 27 analysts covering the stock, the overall consensus rating is a "Moderate Buy." Its mean price target of $319.22 suggests a 14.4% upswing potential from current price levels.

On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com